Investment for Future Business Expansion
First written in FY2016. 8 of 16 entries say "Restated". Latest entry: FY2026.
115 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Total research and development expenses for the fiscal year were ¥5,445 million.」
Research and development expenses increased from ¥4,917 million in the previous fiscal year to ¥5,445 million. Development investment in MBSE, AI, next-generation semiconductors, E3.infinite and the DS series, among others, continued and expanded. - 2026-05-14AdvancedEarnings
「In terms of profit, development expenses increased as we accelerated development, particularly in the MBSE field. However, owing to higher net sales, operating profit and ordinary profit reached record highs for the fifth consecutive period, while net income attributable to owners of the parent reached a record high for the second consecutive period.」
The acceleration of development, particularly in the MBSE field, is explicitly stated, and research and development expenses increased from ¥5,125,926 thousand to ¥5,445,369 thousand. - FY2026-H1AdvancedAnnual report
「Total research and development expenses for the six-month period were ¥2,598 million.」
Research and development expenses increased from ¥2,565.62 million in the year-earlier period to ¥2,598.58 million, indicating continued and expanded development investment for the future. - FY2025-H1AdvancedAnnual report
「Total research and development expenses for the six-month period were ¥2,565 million.」
Research and development expenses increased from ¥2,433.67 million in the year-earlier period to ¥2,565.62 million. Although no material changes were reported in research and development activities, actual development investment increased. - FY2024AdvancedAnnual report
「Total research and development expenses for the fiscal year were ¥4,917 million.」
Research and development expenses increased from ¥4,604 million in the previous fiscal year to ¥4,917 million, while development investment in AI, MBSE/MBD, CR-8000, E3.infinite and the DS series, among others, continued and expanded. - FY2024-Q3AdvancedAnnual report
「In terms of profit, although costs increased due to development investment and more active operating activities, higher sales resulted in operating income of ¥3,149 million, up 4.2% year on year, and ordinary income of ¥3,639 million, up 14.0%. Both reached record highs.」
Development investment continued to intensify, with research and development expenses for the nine-month period increasing to ¥3,631 million from ¥3,363 million in the year-earlier period. - FY2024-Q2RestatedAnnual report
「In terms of profit, although costs increased due to development investment and more active operating activities, substantial sales growth resulted in operating income of ¥1,996 million, up 5.5% year on year」
Development investment continued and was intensified, with research and development expenses reaching ¥2,433.67 million. Although investment increased costs, operating income also rose on higher sales. - FY2024-Q1RestatedAnnual report
「In terms of profit, operating income fell below the year-earlier level because we had increased development investment for the future」
The policy of increasing development investment for the future continues to be cited as a factor weighing on operating income. - FY2023AdvancedAnnual report
「Total research and development expenses for the fiscal year were ¥4,604 million.」
Research and development expenses increased from ¥4,190 million in the previous fiscal year to ¥4,604 million, while development investment in MBSE/MBD, AI, CR-8000, E3.infinite and the DS series, among others, continued and expanded. - FY2023-Q2RestatedAnnual report
「In terms of profit, costs increased due to more active operating activities and expanded development investment, but higher sales resulted in operating income of ¥1,892 million, up 2.2% year on year, and ordinary income of ¥2,093 million, up 7.1%. Both reached record highs for the second consecutive period.」
The continued expansion of development investment is cited as a factor behind the increase in costs, reaffirming the policy of investing for the future. - FY2022-Q3RestatedAnnual report
「Total research and development expenses for the nine-month period ended 31 December were ¥3,151 million. There were no material changes in the status of our group’s research and development activities during the nine-month period ended 31 December.」
Research and development expenses of ¥3,151 million for the nine-month period and the absence of material changes in research and development activities have been reaffirmed. - FY2021RestatedAnnual report
「We focused on expanding the functionality of core products and developing new products.」
It has been reaffirmed that investment and development aimed at future business expansion, including expanding the functionality of core products and developing new products, are continuing. - FY2021-Q3RestatedAnnual report
「In terms of profit, although investment for the future continued, operating income for the latest three-month period increased year on year due to an overall decline in expenses. Ordinary income was ¥1,641 million, down 29.6% year on year, and net income attributable to owners of the parent was ¥1,079 million, down 37.6%. Results improved compared with the first half.」
The policy of continuing investment for the future has also been reaffirmed in the explanation of profit. - FY2021-Q2RestatedAnnual report
「In terms of profit, in addition to the decline in net sales, we continued to promote investment for the future, including the development of new products. As a result, ordinary income was ¥1,068 million, down 41.5% year on year, and net income attributable to owners of the parent was ¥702 million, down 50.5%.」
The policy of promoting investment for the future, including new product development, continues to be cited as a factor behind the decline in profit. - FY2018RestatedAnnual report
「We have actively expanded sales of core products, developed new systems and invested for the future.」
The policy of actively expanding sales of core products, developing new systems and investing to support future business expansion has been reaffirmed. - FY2016First statedAnnual report
「We have actively invested to expand the business in the future.」
This is the first mention of an active investment policy aimed at expanding the business in the future.